Europe's biggest aerospace company Airbus reportedly wants to move away from two of the biggest American technology companies ...

As AI moves to operational reality, PLM companies are prioritizing faster decisions and agentic intelligence integration over ...

The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. | The Trump administration has unveiled yet another new payment model, this one ...

The Centers for Medicare & Medicaid Services (CMS) recently proposed the Guarding US Medicare Against Rising Drug Costs (GUARD) Model, a drug payment model that aims to distribute rebates for certain ...

CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly regulated, dynamic industry – and it’s only becoming more complicated in light of ...

Status Quo designation preserves DFU/VLU reimbursement eligibility for 2026, ensuring continued patient access to BioStem technologyCoverage for ...

CMS has proposed two new models aimed at curbing Medicare drug spending by linking payments to international benchmarks. The proposals — GUARD for Part D drugs and GLOBE for Part B — are the latest in ...

The Centers for Medicare & Medicaid Services (CMS) last week allocated the 400 Medicare-funded residency slots to 135 ...

On December 18, 2025, the Centers for Medicare and Medicaid Services (CMS) issued two proposed rules impacting the ability of providers to deliver gender-affirming care to minors—now termed ...

On Friday, December 19, the Centers for Medicare & Medicaid Services (CMS) announced two new pilot programs aimed at reducing Medicare spending on prescription drugs and reducing beneficiaries’ out-of ...